Generate Biomedicines, Inc Common Stock

Generate Biomedicines, Inc Common Stock

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$4,220
$6,314
$7,224
$3,311
Gross Profit
4,220
6,314
3,951
EBITDA
-87,416
-63,823
-60,838
-58,511
EBIT
-87,416
-67,047
-64,111
-61,639
Net Income
-87,657
-67,255
-61,446
-55,425
Net Change In Cash
4,220
6,314
7,224
3,311
Free Cash Flow
-57,012
-58,877
-84,169
-52,635
Cash
140,350
135,359
160,575
121,650
Basic Shares
128,514
128,240
128,192
127,450

Annual Financials

Values in thousands2025-12-312024-12-31
Revenue
$31,893
$20,459
Gross Profit
31,893
20,459
EBITDA
-208,488
-163,705
EBIT
-221,666
-179,054
Net Income
-203,154
-173,771
Net Change In Cash
31,893
20,459
Free Cash Flow
-204,133
-121,197
Cash
121,650
176,269
Basic Shares
50,088
127,450

Earnings Calls

QuarterEPS
2026-09-30
-$0.68
2026-06-30
-$0.52
2026-03-31
-$1.07